Our Experts Are Your Experts
Expert Community offers insight and analysis on timely topics through articles, white papers and multimedia presentations from PPD’s biopharmaceutical industry thought leaders. Through this robust collection, PPD addresses the most pressing questions facing the clinical research industry.
Listen as Randy Anderson, Ph.D., provides a comprehensive overview of product classes in current development for Type 1 diabetes.
Read a case study describing PPD's partnership agreement to jointly develop and commercialize a DPP4 inhibitor that represented a new class of drugs for the oral treatment of Type 2 diabetes.
Learn about PPD’s proven experience and expertise in diabetes and metabolic research.